![]() |
|
|
,2
,||
*
Minnesota Obesity Center, Minneapolis VA Medical Center, Minneapolis, MN 55417,
Geriatric, Research, Education, and Clinical Center, Minneapolis, MN 55417,
**
Department of Psychiatry, University of Minnesota, Minneapolis, MN 55455,
Department of Food Science and Nutrition, University of Minnesota, St. Paul, MN 55108,
Neuropsychiatric Research Institute, Fargo, ND 58107; and
||
Department of Neuroscience, University of North Dakota School of Medicine and Health Sciences, Fargo, ND 58202
2To whom correspondence should be addressed. E-mail: ALLENL{at}umn.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: sucrose sugar fat opiods neuropeptides dopamine energy expenditure
The concept of "one peptideone macronutrient" has posited that a given neuropeptide controls dietary preferences for a specific macronutrient. In animal studies, morphine and other opioid agonists increased the consumption of fat more potently than the consumption of carbohydrate when the two were offered concurrently, in the form of complete diets or as individual macronutrients (1 4 ). Neuropeptide Y (NPY)3 increased carbohydrate intake more strongly when offered together with fat (5 ). Enterostatin only decreased food intakes of animals chronically maintained on a high fat diet (6 ).
| Appetite for sugar and fat |
|---|
|
|
|---|
An animals food preferences may thus modify the impact of a neuroregulatory agent. Morphine increased intake of a preferred diet rather than selectively increasing intake of a high fat diet (8 ). Rats that were offered a high fat diet and a high carbohydrate diet were classified into carbohydrate-, fat- or intermediate preferrers based on daily food intakes. They were then injected with morphine or saline and offered both diets. Morphine induced intake of fat in rats that preferred fat at baseline; induced intake of carbohydrate in rats that preferred carbohydrate at baseline and had no effect in rats that demonstrated no preference.
Animals exhibit a wide range of food preferences. Some rats prefer lard to corn oil when mixed into a diet. To determine whether morphine-stimulated (1, 3 and 10 mg/kg) food consumption could be modulated by dietary fat source, Glass et al. (9 ) provided rats with a choice between a high fat and high carbohydrate diet, using three sources of dietary fat: vegetable shortening, lard and corn oil. Under normal feeding conditions, rats selected the high fat as opposed to the high carbohydrate diet when the fat was provided by vegetable shortening or lard. Fat and carbohydrate intakes did not differ when the fat was supplied by corn oil. Morphine increased the percentage of dietary fat relative to baseline intakes only for the more preferred diets containing vegetable shortening or lard. Morphine did not stimulate fat consumption in the less-preferred corn oil condition, suggesting that morphine increases the consumption of total energy or preferred diets but not the consumption of fats per se.
Other rats may prefer sugars to cornstarch. In another study (13 ), food consumption was stimulated by deprivation or by the administration of NPY. Rats were provided with a high fat diet and with a high carbohydrate diet containing sucrose, polycose or cornstarch. Spontaneously feeding rats ate more of the high carbohydrate diet when sucrose or polycose was the carbohydrate source. The high fat diet was preferred when the main source of carbohydrate was cornstarch. Food-deprived rats followed a similar pattern of preferences and food consumption. NPY-injected rats ate more of both the high fat and high carbohydrate diets except when the high sucrose and the high fat diets were offered concurrently. In that case, the consumption of the high fat diet did not increase. Although NPY administration and carbohydrate source each influenced diet selection, carbohydrate source had a more marked effect.
Blockade of the opioid receptor was first noted to decrease fat consumption more effectively than carbohydrate consumption (11 ,12 ). However, naloxone was much more effective in decreasing intake of a high sucrose diet than a high cornstarch or high polycose diet in food-restricted rats (13 ). Naloxone failed to reduce the consumption of nonpreferred diets in rats stimulated to eat by deprivation or injection of NPY but was extraordinarily potent in reducing intake of preferred foods (10 ). Naltrexone, a longer-lasting opiate antagonist, decreased intake of carbohydrate and fat diets when injected into the paraventricular nucleus but selectively decreased intake of preferred diets when injected into the central nucleus of the amygdala (14 ). The amygdala, an area involved in pleasure, may participate in the integration of autonomic, gustatory and hedonic signals initiated by sucrose ingestion.
Neurochemical changes.
Ingestion of sugars can result in neurochemical changes in brain regions involved in reward (15 17 ). The provision of a 25% glucose solution together with laboratory diet for 12 h each day, followed by 12 h of deprivation, led to increased binding to dopamine D-1 receptors in the nucleus accumbens shell and core after 30 d. Binding to the dopamine transporter increased in the midbrain. Opioid mu-1 receptor binding also increased in several brain nuclei including the cingulate cortex, hippocampus, accumbens shell and locus ceruleus. Further, behaviors often associated with opiate withdrawal were noted after naloxone was injected in 30-d glucosecycled rats (15 ). Naloxone elevated the levels of the early gene transcription factor, c-Fos, in the central nucleus of the amygdala of rats after 3 wk of 10% sucrose ingestion (17 ).
A diet high in fat and sucrose has been shown to increase gene expression of the opioid dynorphin in the arcuate nucleus (18 ). However this diet had no effect on gene expression of another orexigenic peptide, NPY (18 ). Opioid activity appears to be affected by the intake of palatable and rewarding foods.
Taste preferences.
Naloxone is particularly effective in reducing the intake of pleasant-tasting fluids (19 ). These effects appear to be taste mediated because naloxone injections blocked the intake of a 10% sucrose solution in sham-drinking rats (20 ). The drinking pattern of naloxone-injected rats resembled that seen for 5% sucrose solutions (21 ), suggesting a change in the perceived hedonic tone of sucrose. Naltrexone also decreased the positive hedonic properties of sucrose solutions in rats as measured with the taste reactivity test (22 ). Opiate blockade does not affect the perception of sweetness in humans or rats (23 ,24 ). Humans report that the pleasantness of a sucrose solution is diminished after naltrexone administration (25 27 ).
Opiates may also affect the development of sweet taste preferences. The acquisition of preferences for saccharin was diminished by the daily pretest administration of naloxone (28 ). A peripheral infusion of naltrexone inhibited the redevelopment of a preference for a high sucrose diet after a period of abstinence (29 ). The consumption of a 10% sucrose solution was influenced by endogenous opioids as early as 10 d postnatally (30 ). Shide and Blass (31 ) reported that the development of a conditioned preference for orange odor paired with intraoral sucrose infusion in 6-d-old rats was blocked by naloxone administration.
| Palatability and substance abuse |
|---|
|
|
|---|
Psychostimulants and opiates.
When rats are provided with a palatable solution of glucose and saccharin concurrently with intravenous cocaine, cocaine self-administration is reduced (34 ). Likewise, oral consumption of amphetamine is reduced by access to dietary sucrose or fat (35 ). In other studies, the acquisition of drug-seeking behavior was more rapid in rats with a high sucrose intake at baseline than in rats with a low sucrose intake. In contrast, no relationship was observed between fat intake and subsequent cocaine self-administration (36 ), or between saccharin intake and cocaine (37 ,38 ), at least not in male rats (39 ).
Most research on dietary preferences and opiate intake has dealt with the intake of sweet substances. Rats self-administered less of the opiate etonitazene when a glucose-saccharin solution was present than when it was absent (40 ). Outbred rats selected for high saccharin intake self-administered more morphine than rats selected for low saccharin intake (41 ). In contrast, rats selectively bred for high or low saccharin intake did not differ in the acquisition of heroin self-administration (39 ). In another study, dietary fat consumption at baseline was predictive of subsequent intakes of an 0.8 g of morphine/L solution (42 ).
In humans, heroin and/or methadone users report an increased intake of sugar (43 ,44 ). In measures of subjects in a methadone maintenance program, increased appetite for sugar/sweets was reported during methadone maintenance and when "street using" (45 ). Introspective and retrospective reports of incarcerated drug users (mostly heroin users) suggest that greater craving for sweets was experienced before than after taking the drug (46 ). Higher sugar consumption may be either a consequence of prolonged opiate use or an attempt to substitute for the drug when it is not readily available.
Ethanol.
The intake of ethanol is reduced by the concurrent availability of sugar, fat and saccharin solution (47 ). In outbred rats and in lines of rats selectively bred for high or low ethanol intake, positive relationships have been observed between the intake of saccharin or sucrose and the intake of ethanol (37 ,48 ,49 ). Female rats selectively bred for high alcohol intake (AA rats) consumed more dietary fat than rats bred for low ethanol intake (ANA rats) (50 ). In AA rats, ethanol intake was negatively correlated with carbohydrate intake and positively correlated with protein intake. In other studies (51 ), rats selected for high fat preference consumed more ethanol than rats selected for high carbohydrate preference. However, not all those studies have been replicated (50 ,51 ). Using different lines of alcohol-preferring and nonalcohol-preferring rats, Prasad et al. (52 ) reported that the alcohol-preferring rats consumed less carbohydrate and more protein than the nonalcohol-preferring counterparts. In outbred rats, no relationships were observed between diet preferences and ethanol intake. Although several studies point to a relationship between sweet preference and ethanol intake, the relationship between fat and ethanol intake is unclear.
In newly sober outpatients, the duration of sobriety was associated with increased sugar use in beverages (53 ). Taste preference tests conducted with recently detoxified alcoholics showed that a greater percentage preferred more intense sucrose solutions compared with nonalcoholic controls (54 ). A family history of alcoholism was also associated with increased preference for concentrated sucrose solutions (54 ). However, other studies have failed to link sweet taste preferences with alcoholic status or a family history of alcoholism (55 ,56 ).
| Neuropeptides and energy expenditure |
|---|
|
|
|---|
Manipulations that influence feeding behavior may also affect energy expenditure. Increased NPY gene expression after low fat feeding was accompanied by a marked decrease in the expression of uncoupling protein 1 (UCP1) in brown adipose tissue, suggestive of reduced capacity for thermogenesis (60 ). NPY decreases UCP1 activity in brown adipose tissue (61 ). Bray et al. (62 ,63 ) demonstrated that several regulatory neuropeptides affect the activity of the sympathetic nervous system. Corticotrophin-releasing hormone, glucagon and enterostatin, all of which decrease feeding, result in activation of the sympathetic nervous system (64 66 ), whereas NPY, ß-endorphin and galanin, all of which promote feeding, reduce sympathetic nervous system activation of brown adipose tissue (67 ,68 ). To date, the five UCPs that have been identified all have the capability to uncouple oxidative phosphorylation from ATP synthesis and therefore decrease the efficiency of energy utilization (69 ). Any changes in thermogenic potential by UCP may influence energy balance and therefore increase the propensity to gain body weight (70 ).
UCP1 is located primarily in brown adipose tissue. UCP2 expression is most pronounced in white adipose tissue, and UCP3 is highly concentrated in muscle (69 ). UCP4 and UCP5 (also known as brain mitochondrial protein) are located primarily in brain (71 ). Studies have shown that high fat feeding increases the expression of UCP1, UCP2 and UCP3, with the direction of change being specific for separate tissue depots (72 74 ). Our recent study showed that sucrose feeding for 2 wk led to an elevated UCP3 gene expression in muscle and to decreased energy efficiency, suggesting that sucrose effects on energy balance may be mediated by UCP3 (75 ). Free fatty acids have also been shown to induce the UCP3 gene (74 ).
Dietary manipulations may influence energy expenditure through changes in central neuropeptide activity. Several regulatory neuropeptides at multiple brain sites influence the expression of the UCPs. Data from our laboratory indicate that NPY, cocaine-amphetaminerelated transcript, leptin and urocortin all influenced gene expression of UCP1, UCP2 and UCP3 (61 ,76 79 ). These changes in UCP gene expression may be indicative of changes in the thermogenic potential of adipose tissue.
The impact of regulatory neuropeptides on energy intakes is, for the most part, directly linked to food preferences. Fat and sugar are among the most highly palatable and most preferred foods. Sustained fat and sugar consumption affects neural circuitry in a number of brain areas involved in appetite, reward and energy metabolism. Because many of the brain sites involved in feeding behavior are also important in drug seeking, the ingestion of fats and sugars may affect the self-administration of drugs of abuse. A better understanding of regulatory neuropeptides may aid in the design of improved programs for drug abuse prevention and treatment.
| FOOTNOTES |
|---|
3 Abbreviations used: NPY, neuropeptide Y; UCP, uncoupling protein. ![]()
| LITERATURE CITED |
|---|
|
|
|---|
1. Marks-Kaufman, R. & Kanarek, R. B. (1980) Morphine selectively influences macronutrient intake in the rat. Pharmacol. Biochem. Behav. 12:427-430.[Medline]
2. Marks-Kaufman, R. (1982) Increased fat consumption induced by morphine administration in rats. Pharmacol. Biochem. Behav. 16:949-955.[Medline]
3. Romsos, D. R., Gosnell, B. A., Morley, J. E. & Levine, A. S. (1987) Effects of kappa opiate agonists, cholecystokinin, bombesin on intake of diets varying in carbohydrate-to-fat ratio in rats. J. Nutr. 117:976-985.
4. Welch, C. C., Grace, M. K., Billington, C. J. & Levine, A. S. (1994) Preference and diet type affect macronutrient selection after morphine, NPY, norepinephrine, and deprivation. Am J. Physiol. 266:R426-R433.
5. Stanley, B. G., Daniel, D. R., Chin, A. S. & Leibowitz, S. F. (1985) Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion. Peptides 6:1205-1211.[Medline]
6. Lin, L. & York, D. A. (1998) Chronic ingestion of dietary fat is a prerequisite for inhibition of feeding by enterostatin. Am. J. Physiol. 275:R619-R623.
7. Tordoff, M. G. (2002) Obesity by choice: the powerful influence of nutrient availability on nutrient intake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R1536-R1539.
8. Gosnell, B. A., Krahn, D. D. & Majchrzak, M. J. (1990) The effects of morphine on diet selection are dependent upon baseline diet preferences. Pharmacol. Biochem. Behav. 37:207-212.[Medline]
9. Glass, M. J., Billington, C. J. & Levine, A. S. (1999) Role of lipid type on morphine-stimulated diet selection in rats. Am. J. Physiol. 277:R1345-R1350.
10. Glass, M. J., Grace, M., Cleary, J. P., Billington, C. J. & Levine, A. S. (1996) Potency of naloxones anorectic effect in rats is dependent on diet preference. Am. J. Physiol. 271:R217-R221.
11. Marks-Kaufman, R. & Kanarek, R. B. (1981) Modifications in nutrient selection induced by naloxone in the rat. Psychopharmacology 74:321-324.[Medline]
12. Marks-Kaufman, R. & Kanarek, R. B. (1990) Diet selection following a chronic morphine and naloxone regimen. Pharmacol. Biochem. Behav. 35:665-669.[Medline]
13. Weldon, D. T., OHare, E., Cleary, J., Billington, C. J. & Levine, A. S. (1996) Effect of naloxone on intake of corn starch, sucrose, and polycose diets in restricted and non-restricted rats. Am. J. Physiol. 270:R1183-R1188.
14. Glass, M. J., Billington, C. J. & Levine, A. S. (2000) Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy. Am. J. Physiol. 279:R86-R92.
15. Colantuoni, C., Schwenker, J. & McCarthy, J., et al (2001) Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 12:3549-3552.[Medline]
16. Kim, E.-M., Welch, C. C., Grace, M. K., Billington, C. J. & Levine, A. S. (1998) Effects of palatability induced-induced hyperphagia and food-restriction on mRNA levels of neuropeptide-Y in the arcuate nucleus. Brain Res. 806:117-121.[Medline]
17. Pomonis, J. D., Jewett, D. C., Kotz, C. M., Briggs, J. E., Billington, C. J. & Levine, A. S. (2000) Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:R712-R719.
18. Welch, C. C., Kim, E., Grace, M. K., Billington, C. J. & Levine, A. S. (1996) Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels. Brain Res. 721:126-131.[Medline]
19. Levine, A. S., Murray, S. S., Kneip, J., Grace, M. & Morley, J. E. (1982) Flavor enhances the antidipsogenic effect of naloxone. Physiol. Behav. 28:23-25.[Medline]
20. Rockwood, G. A. & Reid, L. D. (1982) Naloxone modifies sugar-water intake in rats drinking with open gastric fistulas. Physiol. Behav. 29:1175-1178.[Medline]
21. Kirkham, T. C. & Cooper, S. J. (1988) Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol. Behav. 44:491-494.[Medline]
22. Parker, L. A., Maier, S., Rennie, M. & Crebolder, J. (1992) Morphine- and naltrexone-induced modification of palatability: analysis by the taste reactivity test. Behav. Neurosci. 106:999-1010.[Medline]
23. Arbisi, P. A., Billington, C. J. & Levine, A. S. (1999) The effect of naltrexone on taste detection and recognition threshold. Appetite 32:241-249.[Medline]
24. OHare, E., Cleary, J. P., Billington, C. J. & Levine, A. S. (1997) Naloxone administration following operant training of sucrose/water discrimination in the rat. Psychopharmacology 129:289-294.[Medline]
25. Bertino, M., Beauchamp, G. K. & Engelman, K. (1991) Naltrexone, an opiate blocker, alters taste perception and nutrient intake in humans. Am. J. Physiol. 261:R59-R63.
26. Fantino, M., Hosotte, J. & Apfelbaum, M. (1986) An opioid antagonist naltrexone, reduces the preference for sucrose in humans. Am. J. Physiol. 251:R91-R96.
27. Drewnowski, A., Krahn, D. D., Demitrack, M. A., Nairn, K. & Gosnell, B. A. (1992) Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol. Behav. 51:371-379.[Medline]
28. Lynch, W. C. (1986) Opiate blockade inhibits saccharin intake and blocks normal preference acquisition. Pharmacol. Biochem. Behav. 24:833-836.[Medline]
29. Levine, A. S., Grace, M. K., Cleary, J. P. & Billington, C. J. (2003) Naltrexone infusion inhibits the development of preference for a high sucrose diet. Am. J. Physiol. In press.
30. Philopena, J., Greenberg, D. & Smith, G. P. (1996) Naloxone decreases intake of 10% sucrose in preweanling rats. Pharmacol. Biochem. Behav. 54:333-337.[Medline]
31. Shide, D. J. & Blass, E. M. (1991) Opioid mediation of odor preferences induced by sugar and fat in 6-day-old rats. Physiol. Behav. 50:961-966.[Medline]
32. Martel, P. & Fantino, M. (1996) Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study. Pharmacol. Biochem. Behav. 53:221-226.[Medline]
33. Hajnal, A. & Norgren, R. (2001) Accumbens dopamine mechanisms in sucrose intake. Brain Res. 904:76-84.[Medline]
34. Carroll, M. E., Lac, S. T. & Nygaard, S. L. (1989) A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior. Psychopharmacology (Berl.) 97:23-29.[Medline]
35. Kanarek, R. B., Mathes, W. F. & Przypek, J. (1996) Intake of dietary sucrose or fat reduces amphetamine drinking in rats. Pharmacol. Biochem. Behav. 54:719-723.[Medline]
36. Gosnell, B. A. (2000) Sucrose intake predicts rate of acquisition of cocaine self-administration. Psychopharmacology (Berl.) 149:286-292.[Medline]
37. Gahtan, E., Labounty, L. P., Wyvell, C. & Carroll, M. E. (1996) The relationships among saccharin consumption, oral ethanol, and i.v. cocaine self-administration. Pharmacol. Biochem. Behav. 53:919-925.[Medline]
38. Gosnell, B. A., Krahn, D. D., Yracheta, J. M. & Harasha, B. J. (1998) The relationship between intravenous cocaine self-administration and avidity for saccharin. Pharmacol. Biochem. Behav. 60:229-236.[Medline]
39. Carroll, M. E., Morgan, A. D., Lynch, W. J., Campbell, U. C. & Dess, N. K. (2002) Intravenous cocaine and heroin self-administration in rats selectively bred for differential saccharin intake: phenotype and sex differences. Psychopharmacology (Berl.) 161:304-313.[Medline]
40. Carroll, M. E. & Boe, I. N. (1982) Increased intravenous drug self-administration during deprivation of other reinforcers. Pharmacol. Biochem. Behav. 17:563-567.[Medline]
41. Gosnell, B. A., Lane, K. E., Bell, S. M. & Krahn, D. D. (1995) Intravenous morphine self-administration by rats with low versus high saccharin preferences. Psychopharmacology (Berl.) 117:248-252.[Medline]
42. Marks-Kaufman, R. & Lipeles, B. J. (1982) Patterns of nutrient selection in rats orally self-administering morphine. Nutr. Behav. :1.
43. Morabia, A., Fabre, J., Chee, E., Zeger, S., Orsat, E. & Robert, A. (1989) Diet and opiate addiction: a quantitative assessment of the diet of non-institutionalized opiate addicts. Br. J. Addict. 84:173-180.[Medline]
44. Zador, D., Lyons, , Wall, P. M. & Webster, I. (1996) High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia. Addiction 91:1053-1061.[Medline]
45. Willenbring, M. L., Morley, J. E., Krahn, D. D., Carlson, G. A., Levine, A. S. & Shafer, R. B. (1989) Psychoneuroendocrine effects of methadone maintenance. Psychoneuroendocrinology 14:371-391.[Medline]
46. Weiss, G. (1982) Food fantasies of incarcerated drug users. Int. J. Addict. 17:905-912.[Medline]
47. Lester, D. & Greenberg, L. A. (1952) The effect of sucrose, saccharin and fat on the self-selection of ethyl alcohol by rats. Q. J. Stud. Alcohol 13:553-560.
48. Gosnell, B. A. & Krahn, D. D. (1992) The relationship between saccharin and alcohol intake in rats. Alcohol 9:203-206.[Medline]
49. Kampov-Polevoy, A. B., Garbutt, J. C. & Janowsky, D. S. (1999) Association between preference for sweets and excessive alcohol intake: a review of animal and human studies. Alcohol Alcohol. 34:386-395.
50. Forsander, O. A. (1988) The interaction between voluntary alcohol consumption and dietary choice. Alcohol Alcohol. 23:143-149.
51. Krahn, D. D. & Gosnell, B. A. (1991) Fat-preferring rats consume more alcohol than carbohydrate-preferring rats. Alcohol 8:313-316.[Medline]
52. Prasad, A., Abadie, J. M. & Prasad, C. (1993) Can dietary macronutrient preference profile serve as a predictor of voluntary alcohol consumption?. Alcohol 10:485-489.[Medline]
53. Yung, L., Gordis, E. & Holt, J. (1983) Dietary choices and likelihood of abstinence among alcoholic patients in an outpatient clinic. Drug Alcohol Depend. 12:355-362.[Medline]
54. Kampov-Polevoy, A. B., Tsoi, M. V., Zvartau, E. E., Neznanov, N. G. & Khalitov, E. (2001) Sweet liking and family history of alcoholism in hospitalized alcoholic and non-alcoholic patients. Alcohol Alcohol. 36:165-170.
55. Bogucka-Bonikowska, A., Scinska, A. & Koros, E., et al (2001) Taste responses in alcohol-dependent men. Alcohol Alcohol. 36:516-519.
56. Kranzler, H. R., Sandstrom, K. A. & Van Kirk, J. (2001) Sweet taste preference as a risk factor for alcohol dependence. Am. J. Psychiatry 158:813-815.
57. Giraudo, S. Q., Kotz, C. A., Grace, M. K., Levine, A. S. & Billington, C. J. (1994) Rat hypothalamic NPY mRNA and brown fat uncoupling protein mRNA after high-carbohydrate or high-fat diets. Am. J. Physiol. 266:R1578-R1583.
58. Laugero, K. D., Bell, M. E., Bhatnagar, S., Soriano, L. & Dallman, M. F. (2001) Sucrose ingestion normalizes central expression of corticotropin- releasing-factor messenger ribonucleic acid and energy balance in adrenalectomized rats: a glucocorticoid-metabolic-brain axis?. Endocrinology 142:2796-2804.
59. Lin, L. & York, D. A. (1998) Chronic ingestion of dietary fat is a prerequisite for inhibition of feeding by enterostatin. Am. J. Physiol. 275:R619-R623.
60. Giraudo, S. Q., Kotz, C. M., Grace, M. K., Levine, A. S. & Billington, C. J. (1994) Rat hypothalamic NPY mRNA and brown fat uncoupling protein mRNA after high-carbohydrate or high-fat diets. Am. J. Physiol. 266:R1578-R1583.
61. Billington, C. J., Briggs, J. E., Harker, S., Grace, M. & Levine, A. S. (1994) Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am. J. Physiol. 266:R1765-R1770.
62. Bray, G. A. (1992) Peptides affect the intake of specific nutrients and the sympathetic nervous system. Am. J. Clin. Nutr. 55:265S-271S1992.
63. Bray, G. A. (1993) The nutrient balance hypothesis: peptides, sympathetic activity, and food intake. Ann. N. Y. Acad. Sci. 676:223-241.[Abstract]
64. Egawa, M., Yoshimatsu, H. & Bray, G. A. (1990) Effect of corticotropin releasing hormone and neuropeptide Y on electrophysiological activity of sympathetic nerves to interscapular brown adipose tissue. Neuroscience 34:771-775.[Medline]
65. Shimizu, H., Egawa, M., Yoshimatsu, H. & Bray, G. A. (1993) Glucagon injected in the lateral hypothalamus stimulates sympathetic activity and suppresses monoamine metabolism. Brain Res. 630:95-100.[Medline]
66. Nagase, H., Bray, G. A. & York, D. A. (1996) Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue. Brain Res. 709:44-50.[Medline]
67. Egawa, M., Yoshimatsu, H. & Bray, G. A. (1991) Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am. J. Physiol. 260:R328-R334.
68. Egawa, M., Yoshimatsu, H. & Bray, G. A. (1993) Effect of beta-endorphin on sympathetic nerve activity to interscapular brown adipose tissue. Am. J. Physiol. 264:R109-R115.
69. Boss, O., Muzzin, P. & Giacobino, J. P. (1998) The uncoupling proteins: a review. Eur. J. Endocrinol. 139:1-9.[Medline]
70. Ravussin, E. (1995) Metabolic differences and the development of obesity. Metabolism 44:12-14.[Medline]
71. Mao, W., Yu, X. X., Zhong, A., Li, W., Brush, J. & Sherwood, S. W. (1999) UCP4, a novel brain-specific mitochondrial uncoupling protein that reduces membrane potential in mammalian cells. FEBS Lett. 443:326-330.[Medline]
72. Matsuda, J., Hosoda, K. & Itoh, H., et al (1997) Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet. FEBS Lett. 418:200-204.[Medline]
73. Rippe, C., Berger, K., Boiers, C., Ricquier, D. & Erlanson-Albertsson, C. (2000) Effect of high-fat diet, surrounding temperature, and enterostatin on uncoupling protein gene expression. Am. J. Physiol. Endocrinol. Metab. 279:E293-E300.
74. Weigle, D. S., Selfridge, L. E. & Schwartz, M. W., et al (1998) Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting. Diabetes 47:298-302.[Abstract]
75. Levine, A. S., Kotz, C. M. & Gosnell, B. A. (2003) Sugars: hedonic aspects, neuroregulation and energy balance. Am. J. Clin. Nutr. In press.
76. Kotz, C. M., Briggs, J. E., Pomonis, J. D., Grace, M. K., Levine, A. S. & Billington, C. J. (1998) Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein. Am. J. Physiol. 275:R478-R484.
77. Kotz, C. M., Wang, C. F., Briggs, J. E., Levine, A. S. & Billington, C. J. (2000) Effect of NPY in the hypothalamic paraventricular nucleus on uncoupling proteins 1, 2, and 3 in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:R494-R498.
78. Kotz, C. M., Wang, C., Levine, A. S. & Billington, C. J. (2002) Urocortin in the hypothalamic PVN increases leptin and affects uncoupling proteins-1 and -3 in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R546-R551.
79. Wang, C., Billington, C. J., Levine, A. S. & Kotz, C. M. (2000) Effect of CART in the hypothalamic paraventricular nucleus on feeding and uncoupling protein gene expression. Neuroreport 11:3251-3255.[Medline]
This article has been cited by other articles:
![]() |
A. M. Naleid, M. K. Grace, M. Chimukangara, C. J. Billington, and A. S. Levine Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R99 - R105. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Drewnowski The Real Contribution of Added Sugars and Fats to Obesity Epidemiol. Rev., June 24, 2007; (2007) mxm011v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wu, Y. Zhang, J. Xu, and P. Shen Regulation of hunger-driven behaviors by neural ribosomal S6 kinase in Drosophila PNAS, September 13, 2005; 102(37): 13289 - 13294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Drewnowski and N. Darmon The economics of obesity: dietary energy density and energy cost Am. J. Clinical Nutrition, July 1, 2005; 82(1): 265S - 273S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Drewnowski, N. Darmon, and A. Briend Replacing Fats and Sweets With Vegetables and Fruits--A Question of Cost Am J Public Health, September 1, 2004; 94(9): 1555 - 1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. de Graaf, W. A. Blom, P. A. Smeets, A. Stafleu, and H. F. Hendriks Biomarkers of satiation and satiety Am. J. Clinical Nutrition, June 1, 2004; 79(6): 946 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Drewnowski and S. Specter Poverty and obesity: the role of energy density and energy costs Am. J. Clinical Nutrition, January 1, 2004; 79(1): 6 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Drewnowski and A. S. Levine Sugar and Fat-From Genes to Culture J. Nutr., March 1, 2003; 133(3): 829S - 830. [Full Text] [PDF] |
||||
![]() |
A. Drewnowski Fat and Sugar: An Economic Analysis J. Nutr., March 1, 2003; 133(3): 838S - 840. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||